Additional funding for Chronic kidney disease research
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
Showing 221 - 240 of 1132 results
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP manufacture of an emerging prostate cancer therapy, following the launch of a new joint venture between Cyclotek and ANSTO.
A tiny 8mm by 6mm radioactive capsule went missing in January 2023, somewhere along a 1400 kilometre journey from Rio Tinto’s Gudai-Darri iron ore mine to its final destination in Perth, Western Australia. Find out how ANSTO's CORIS360® technology identified the exact location of the missing source.
ANSTO has just completed the largest coordinated safety and security review of the OPAL multi-purpose research reactor, as part of a new a world-leading approach to assessing performance
Report to the independent nuclear regulator, ARPANSA, and the IAEA
Come and discover the world of nuclear science at ANSTO - book a school tour in Sydney today.
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.
Meeting of minds about potential next-generation cancer treatment for Australians
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
ANSTO’s food provenance research gathers momentum with progress on the development of handheld technology for off-site assessments of origin tiger prawns and an expansion of the work to other seafood species.
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.
The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
ANSTO offers a diverse range of career opportunities within science, engineering, corporate services and trade disciplines.
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.